Dabigatran Capsule
Product Images NDC 50268-200

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dabigatran (NDC 50268-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (200 11)

FDA Label Image

1 (200 15)

FDA Label Image

Dabigatran-etexilate-figure-1 (Dabigatran Etexilate Figure 1)

FDA Label Image

Dabigatran-etexilate-figure-2 (Dabigatran Etexilate Figure 2)

FDA Label Image

Dabigatran-etexilate-figure-3-1 (Dabigatran Etexilate Figure 3 1)

Not available.*

FDA Label Image

Dabigatran-etexilate-figure-3-2 (Dabigatran Etexilate Figure 3 2)

This text appears to be a list of different drugs and their specific dosages and frequencies of use. The text also includes mentions of parameters and calculations related to pharmacokinetics (PK) like AUC (area under the curve) and Cmax (maximum plasma concentration), as well as fold change and 90% confidence intervals. The content seems to pertain to drug interactions, time differences in drug administration, and comparisons between different medications. The text suggests a detailed study or analysis related to drug efficacy and dosage adjustments.*

FDA Label Image

Dabigatran-etexilate-figure-4 (Dabigatran Etexilate Figure 4)

FDA Label Image

Dabigatran-etexilate-figure-5 (Dabigatran Etexilate Figure 5)

FDA Label Image

Dabigatran-etexilate-structure (Dabigatran Etexilate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.